NO166485C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4h-pyrrolo(3,3-d)-pyrimidin-4-oner. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 4h-pyrrolo(3,3-d)-pyrimidin-4-oner.Info
- Publication number
- NO166485C NO166485C NO87873584A NO873584A NO166485C NO 166485 C NO166485 C NO 166485C NO 87873584 A NO87873584 A NO 87873584A NO 873584 A NO873584 A NO 873584A NO 166485 C NO166485 C NO 166485C
- Authority
- NO
- Norway
- Prior art keywords
- pyrrolo
- oner
- pyrimidin
- preparation
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Luminescent Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90048686A | 1986-08-26 | 1986-08-26 | |
| US5941987A | 1987-06-18 | 1987-06-18 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO873584D0 NO873584D0 (no) | 1987-08-25 |
| NO873584L NO873584L (no) | 1988-02-29 |
| NO166485B NO166485B (no) | 1991-04-22 |
| NO166485C true NO166485C (no) | 1991-07-31 |
Family
ID=26738724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO87873584A NO166485C (no) | 1986-08-26 | 1987-08-25 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4h-pyrrolo(3,3-d)-pyrimidin-4-oner. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0260491B1 (da) |
| JP (2) | JP2595254B2 (da) |
| KR (2) | KR940008421B1 (da) |
| AT (1) | ATE67203T1 (da) |
| AU (1) | AU619724B2 (da) |
| CA (2) | CA1293727C (da) |
| DE (1) | DE3772913D1 (da) |
| DK (1) | DK169705B1 (da) |
| ES (1) | ES2038635T3 (da) |
| FI (1) | FI85856C (da) |
| GR (1) | GR3002697T3 (da) |
| IE (1) | IE60433B1 (da) |
| NO (1) | NO166485C (da) |
| NZ (1) | NZ221463A (da) |
| PH (1) | PH24669A (da) |
| PT (1) | PT85582B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1294960C (en) * | 1986-10-24 | 1992-01-28 | Thomas C. Malone | 7-deazaguanines as immunomodulators |
| ATE157363T1 (de) * | 1989-02-27 | 1997-09-15 | Biocryst Pharm Inc | 9-substituierte-8-unsubstituierte-9-deazaguanin |
| CA2072123C (en) * | 1989-10-31 | 2001-06-12 | John A. Secrist, Iii | Inhibitors of purine nucleoside phosphorylase |
| US5726311A (en) * | 1989-11-29 | 1998-03-10 | Biocryst Pharmaceuticals, Inc. | 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo 3,2-d!pyrimidine and pharmaceutical uses and compositions containing the same |
| AU6855594A (en) * | 1993-06-30 | 1995-01-24 | Biocryst Pharmaceuticals, Inc. | 9-deazahypoxanthines as pnp inhibitors |
| US5386031A (en) * | 1993-12-15 | 1995-01-31 | Warner-Lambert Company | Process for the synthesis of 2-amino-3,5-dihydro-7-substituted-4H-pyrrolo[3,]pyrimidin-4-ones |
| WO1996011200A1 (en) * | 1994-10-05 | 1996-04-18 | Chiroscience Limited | Purine and guanine compounds as inhibitors of pnp |
| FR2728181B1 (fr) * | 1994-12-16 | 1997-01-31 | Appryl Snc | Composante catalytique pour la polymerisation des olefines, son procede de fabrication, et procede de polymerisation des olefines en presence de ladite composante catalytique |
| DE69531558T2 (de) * | 1995-06-07 | 2004-03-18 | Pfizer Inc. | Heterocyclische kondensierte pyrimidin-derivate |
| US6395733B1 (en) | 1995-06-07 | 2002-05-28 | Pfizer Inc | Heterocyclic ring-fused pyrimidine derivatives |
| NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
| KR20060120069A (ko) * | 2003-10-03 | 2006-11-24 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 피라졸로피리딘 및 그의 유사체 |
| NZ540160A (en) * | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
| GB201417165D0 (en) * | 2014-09-29 | 2014-11-12 | Provost Fellows & Scholars College Of The Holy Undivided Trinity Of Queen Elizabeth Near Dublin | Treatments for Autoimmune Disease |
| GB201417163D0 (en) | 2014-09-29 | 2014-11-12 | Provost Fellows & Scholars College Of The Holy Undivided Trinity Of Queen Elizabeth Near Dublin | Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN164556B (da) * | 1986-03-06 | 1989-04-08 | Takeda Chemical Industries Ltd | |
| CA1294960C (en) * | 1986-10-24 | 1992-01-28 | Thomas C. Malone | 7-deazaguanines as immunomodulators |
| DE3739366A1 (de) * | 1987-04-10 | 1988-10-27 | Boehringer Mannheim Gmbh | Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel |
-
1987
- 1987-07-30 IE IE207087A patent/IE60433B1/en not_active IP Right Cessation
- 1987-07-30 CA CA000543431A patent/CA1293727C/en not_active Expired - Fee Related
- 1987-08-17 NZ NZ221463A patent/NZ221463A/xx unknown
- 1987-08-24 FI FI873648A patent/FI85856C/fi not_active IP Right Cessation
- 1987-08-24 PH PH35723A patent/PH24669A/en unknown
- 1987-08-24 DK DK440287A patent/DK169705B1/da not_active IP Right Cessation
- 1987-08-25 AU AU77416/87A patent/AU619724B2/en not_active Ceased
- 1987-08-25 PT PT85582A patent/PT85582B/pt not_active IP Right Cessation
- 1987-08-25 ES ES87112339T patent/ES2038635T3/es not_active Expired - Lifetime
- 1987-08-25 EP EP87112339A patent/EP0260491B1/en not_active Expired - Lifetime
- 1987-08-25 DE DE8787112339T patent/DE3772913D1/de not_active Expired - Fee Related
- 1987-08-25 JP JP62209423A patent/JP2595254B2/ja not_active Expired - Fee Related
- 1987-08-25 AT AT87112339T patent/ATE67203T1/de not_active IP Right Cessation
- 1987-08-25 NO NO87873584A patent/NO166485C/no unknown
- 1987-08-26 KR KR1019870009320A patent/KR940008421B1/ko not_active IP Right Cessation
-
1991
- 1991-03-07 CA CA000616019A patent/CA1320203C/en not_active Expired - Fee Related
- 1991-09-12 GR GR91401215T patent/GR3002697T3/el unknown
-
1994
- 1994-06-08 KR KR1019940012787A patent/KR940008848B1/ko not_active IP Right Cessation
-
1996
- 1996-06-05 JP JP8142606A patent/JP2650644B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI873648A (fi) | 1988-02-27 |
| ES2038635T3 (es) | 1993-08-01 |
| EP0260491A1 (en) | 1988-03-23 |
| IE872070L (en) | 1988-02-26 |
| PT85582A (en) | 1987-09-01 |
| FI85856C (fi) | 1992-06-10 |
| KR940008848B1 (ko) | 1994-09-28 |
| FI873648A0 (fi) | 1987-08-24 |
| JP2650644B2 (ja) | 1997-09-03 |
| NO873584D0 (no) | 1987-08-25 |
| ATE67203T1 (de) | 1991-09-15 |
| IE60433B1 (en) | 1994-07-13 |
| KR880002873A (ko) | 1988-05-12 |
| EP0260491B1 (en) | 1991-09-11 |
| JP2595254B2 (ja) | 1997-04-02 |
| NO873584L (no) | 1988-02-29 |
| AU619724B2 (en) | 1992-02-06 |
| NO166485B (no) | 1991-04-22 |
| DK169705B1 (da) | 1995-01-16 |
| JPH08311040A (ja) | 1996-11-26 |
| GR3002697T3 (en) | 1993-01-25 |
| JPS6388185A (ja) | 1988-04-19 |
| FI85856B (fi) | 1992-02-28 |
| NZ221463A (en) | 1990-07-26 |
| DK440287D0 (da) | 1987-08-24 |
| KR940008421B1 (ko) | 1994-09-14 |
| AU7741687A (en) | 1988-03-03 |
| CA1320203C (en) | 1993-07-13 |
| PH24669A (en) | 1990-09-07 |
| DK440287A (da) | 1988-02-27 |
| CA1293727C (en) | 1991-12-31 |
| PT85582B (pt) | 1990-05-31 |
| DE3772913D1 (de) | 1991-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO166485C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4h-pyrrolo(3,3-d)-pyrimidin-4-oner. | |
| MY104043A (en) | Therapeutic nucleosides. | |
| AU591125B2 (en) | Therapeutic nucleosides | |
| DE69432087D1 (de) | 6-Amino-purinderivate mit PDE-IV inhibierender Wirkung | |
| AU4690989A (en) | Antiviral cytosine and guanine derivatives | |
| HUT52769A (en) | Process for producing pyrimidine derivatives and pharmaceutical compositions containing them | |
| NO168423C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive bis-(hydroksymetyl) -cyklobutylpuriner og -pyrimidiner | |
| ATE296309T1 (de) | Wasserlösliche adenosin kinase inhibitoren | |
| ATE282628T1 (de) | Oral aktive adenosinkinase-inhibitoren | |
| MY104575A (en) | Therapeutic nucleosides. | |
| LV5273A3 (lv) | Panemiens pirimidinnukleozidu iegusanai | |
| DK322189D0 (da) | Imidazo(1,2-a)-(pyridaziner eller pyraziner) til behandling af sygdomme med relation til knogletab | |
| NO172986C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 9h-puriner | |
| ATE63747T1 (de) | Antivirale verbindungen. | |
| NO167028C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)pyrimidinderivater | |
| EP0351215A3 (en) | Ester of 9-(2-hydroxyethoxymethyl) guanine | |
| AU2527688A (en) | Artificial dna base pair analogues | |
| HU896136D0 (en) | Process for producing compounds with antiviral effect and pharmaceutical compositions comprising same | |
| ES2062351T3 (es) | Derivados de triazolo (4,5-c) piridina anticonvulsivos. | |
| NO163530C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-substituerte-5-fenyltetrazolo-(1,5-a) (1,2,4)-triazolo(1,5-c)pyrimidiner. |